Spinal Muscular Atrophy Type I
Rare Disease·MeSH: Spinal Muscular Atrophies of Childhood
Prevalence
0.1 / 100K
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| gb221 | IMMAGE BIOTHERAPEUTICS CORP. (IMMG) |
Frequently asked questions
How many drugs are in development for Spinal Muscular Atrophy Type I?
BioSniper tracks 1 drug in development for Spinal Muscular Atrophy Type I across 1 company.
How many clinical trials target Spinal Muscular Atrophy Type I?
There are 1 clinical trial targeting Spinal Muscular Atrophy Type I tracked by BioSniper.
What is the prevalence of Spinal Muscular Atrophy Type I?
The estimated prevalence of Spinal Muscular Atrophy Type I is approximately 0.1 per 100,000 population.
Deep-dive into Spinal Muscular Atrophy Type I
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis